PBLTT52CAR19

N/A

Report date: 2024/11/07 11:50:14

Base Information

Drug NamePBLTT52CAR19

Drug Alias NameCRISPR-CAR Genome Edited T Cells (Great Ormond Street Hospital for Children NHS Foundation Trust)PBLTT52CAR19 modified T cells (Great Ormond Street Hospital for Children NHS Foundation Trust)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-CD19

TargetsB-lymphocyte antigen CD19

Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGreat Ormond Street Hospital For Children Nhs Foundation Trust

China Registration ClassN/A

Develop Information

Active CompaniesGreat Ormond Street Hospital For Children Nhs Foundation Trust

Inactive CompaniesN/A

Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A